Patent Assignment
Reel/Frame 015621/0835
Assignment of Assignor's Interest
Recorded: 2005-01-28
Received: 2005-01-28
Pages: 3
Assignor
THE UNIVERSITY OF SOUTH FLORIDA
Executed: 2004-11-16
Assignee
ROSKAMP RESEARCH LLC
1226 N. TAMIAMI TRAIL, SARASOTA, FL, 34236, UNITED STATES
Covered Properties
(12)
Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
Application:
10/780,905 →
Organic anion transport polypeptide related protein-4 (OATPRP4) gene in Tourette syndrome and related disorders
Application:
10/702,129 →
PCT:
PCTUS2003035372 ↗
Methods and Compounds for Disruption of CD40R/CD40L Signaling in the Treatment of Alzheimer's Disease
Application:
10/694,634 →
PCT:
PCTUS2003033971 ↗
Method and assay for diagnosing substance dependency
Application:
10/638,571 →
CD45 Isoform Alteration in CD4+ T Cells as a Potential Diagnostic Marker in Alzheimer's Disease
Application:
10/426,301 →
Methods of identifying compounds useful in the inhibition of neurodegenerative disease
Application:
10/305,508 →
Inhibition of Angiogenesis by a-Beta Peptides
Application:
10/217,584 →
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
Application:
10/218,004 →
Modulation of Angiogenesis by a-Beta Peptides
PCT:
PCTUS2002027040 ↗
Methods and Compounds for Disruption of CD4OR/CD40L Signaling in the Treatment of Alzheimer's Disease
PCT:
PCTUS2002027035 ↗
Methods and Compositions for Stimulating CD45 and Thereby Suppressing Microglial Activation Associated with Alzheimer's Disease
PCT:
PCTUS2001042909 ↗
Modulation of the Phospholipase A2 Pathway as a Therapeutic
Application:
09/743,781 →